Neurovascular Devices Market Size, Share & Trends Analysis Report by Device, Therapeutic Applications, End Use, Region, and Segment Forecasts, 2026-2033

The global neurovascular devices market size was estimated at USD 7.78 billion in 2025 and is projected to reach USD 11.91 billion by 2033, growing at a CAGR of 5.40% from 2026 to 2033. The market is driven by the rising prevalence of neurovascular disorders, advancements in medical technology, and an increasing focus on minimally invasive procedures.

As conditions such as stroke, cerebral aneurysms, and Arteriovenous Malformations (AVM) become more common, the demand for effective treatment options also increases. The increasing prevalence of neurovascular diseases such as strokes and aneurysms is a major driving force behind the market. Various neurovascular devices, including clot retrieval devices, microcatheters, and flow diversion coils, are utilized to treat these conditions. According to the Global Stroke Fact Sheet 2024 published by the World Stroke Organization (WSO), more than 12 million new strokes occur annually, and about 25% of the global population will experience a stroke in their lifetime.

The burden of neurovascular disorders such as strokes is increasing significantly, which is anticipated to propel the demand for neurovascular devices such as neurothrombectomy devices like clot retrievers and suction devices, among others.

In addition, data released by the Brain Aneurysm Foundation in August 2024 indicates that an unruptured brain aneurysm affects an estimated 6.8 million people in the U.S., with around 30,000 individuals suffering a brain aneurysm rupture each year. As a result, the significant number of patients affected by neurovascular diseases and the increasing use of neurovascular devices in their treatment are expected to drive market growth in the coming years.

Global Neurovascular Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global neurovascular devices market report based on device, application, end use, and region:

Device Outlook (Revenue USD Million, 2021-2033)
Cerebral Embolization and Aneurysm Coiling Devices
Cerebral Angioplasty and Stenting Systems
Neurothrombectomy Devices
Support Devices""""""""
Trans Radial Access Devices
Therapeutic Application Outlook (Revenue USD Million, 2021-2033)
Stroke
Cerebral Artery
Cerebral Aneurysm
Others
End Use Outlook (Revenue USD Million, 2021-2033)
Hospitals
Specialty Clinics
Others
Regional Outlook (Revenue USD Million, 2021-2033)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Why You Should Buy This Report

Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
Competitive Landscape: Explore the market presence of key players.
Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

Market intelligence to enable effective decision-making
Market estimates and forecasts from 2018 to 2030
Growth opportunities and trend analyses
Segment and regional revenue forecasts for market assessment
Competition strategy and market share analysis
Product innovation listings for you to stay ahead of the curve

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Device
1.2.2. Therapeutic Applications
1.2.3. End Use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Neurovascular Diseases
3.2.1.2. Technological Advancements In Neurovascular Devices
3.2.1.3. Rising Number of Awareness Initiatives
3.2.1.4. Increasing Demand For Minimally Invasive Procedures
3.2.2. Market Restraint Analysis
3.2.2.1. Product Recalls
3.2.2.2. High Treatment Cost Associated With Neurovascular Disorders
3.2.3. Market Opportunity Analysis
3.2.3.1. Growing Number of Clinical Trials
3.2.3.2. Launches Of Novel Products
3.2.3.3. Increasing Research & Development Activities
3.2.4. Market Challenge Analysis
3.2.4.1. Shortage of Skilled Professionals
3.2.4.2. Potential Complications & Risks associated with Neurovascular Devices
3.3. Neurovascular Devices Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2021-2033 (USD Million)

4.1. Definition and Scope
4.2. Segment Dashboard
4.3. Device Market Share Analysis, 2025 & 2033
4.4. Global Neurovascular Devices Market, by Device, 2021 to 2033
4.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
4.5.1. Cerebral Embolization and Aneurysm coiling devices
4.5.1.1. Cerebral embolization and aneurysm coiling devices market, 2021-2033 (USD Million)
4.5.1.2. Embolic coils
4.5.1.2.1. Embolic coils market, 2021-2033 (USD Million)
4.5.1.3. Flow diverters
4.5.1.3.1. Flow diverters market, 2021-2033 (USD Million)
4.5.1.4. Liquid embolic agents
4.5.1.4.1. Liquid embolic agents market, 2021-2033 (USD Million)
4.5.2. Cerebral angioplasty and stenting systems
4.5.2.1. Cerebral angioplasty and stenting systems market, 2021-2033 (USD Million)
4.5.2.2. Carotid Artery Stents
4.5.2.2.1. Carotid artery stents market, 2021-2033 (USD Million)
4.5.2.3. Embolic Protection Devices
4.5.2.3.1. Embolic protection systems devices market, 2021-2033 (USD Million)
4.5.3. Neurothrombectomy devices
4.5.3.1. Neurothrombectomy devices market, 2021-2033 (USD Million)
4.5.3.2. Clot Retrieval Devices
4.5.3.2.1. Clot retrieval devices market, 2021-2033 (USD Million)
4.5.3.3. Suction Devices
4.5.3.3.1. Suction devices market, 2021-2033 (USD Million)
4.5.3.4. Vascular Snares
4.5.3.4.1. Vascular snares market, 2021-2033 (USD Million)
4.5.4. Support devices
4.5.4.1. Support devices market, 2021-2033 (USD Million)
4.5.4.2. By Product
4.5.4.2.1. Micro Catheters
4.5.4.2.1.1. Micro catheters market, 2021-2033 (USD Million)
4.5.4.2.2. Micro Guidewires
4.5.4.2.2.1. Micro guidewires market, 2021-2033 (USD Million)
4.5.4.3. By Size
4.5.4.3.1. 0.027"
4.5.4.3.1.1. 0.027" market, 2021-2033 (USD Million)
4.5.4.3.2. 0.021"
4.5.4.3.2.1. 0.021" market, 2021-2033 (USD Million)
4.5.4.3.3. 0.071"
4.5.4.3.3.1. 0.071" market, 2021-2033 (USD Million)
4.5.4.3.4. 0.017"
4.5.4.3.4.1. 0.017" market, 2021-2033 (USD Million)
4.5.4.3.5. 0.019"
4.5.4.3.5.1. 0.019" market, 2021-2033 (USD Million)
4.5.4.3.6. 0.013"
4.5.4.3.6.1. 0.013" market, 2021-2033 (USD Million)
4.5.4.3.7. 0.058"
4.5.4.3.7.1. 0.058" market, 2021-2033 (USD Million)
4.5.4.3.8. 0.068"
4.5.4.3.8.1. 0.068" market, 2021-2033 (USD Million)
4.5.4.3.9. Others
4.5.4.3.9.1. Others market, 2021-2033 (USD Million)
4.5.5. Trans Radial Access Devices
4.5.5.1. Trans radial access devices market, 2021-2033 (USD Million)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2021-2033 (USD Million)

5.1. Definition and Scope
5.2. Segment Dashboard
5.3. Therapeutic Applications Market Share Analysis, 2025 & 2033
5.4. Global Neurovascular Devices Market, by Therapeutic Applications, 2021 to 2033
5.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
5.5.1. Stroke
5.5.1.1. Stroke market, 2021-2033 (USD Million)
5.5.2. Cerebral artery stenosis
5.5.2.1. Cerebral artery stenosis market, 2021-2033 (USD Million)
5.5.3. Cerebral aneurysm
5.5.3.1. Cerebral aneurysm market, 2021-2033 (USD Million)
5.5.3.2. Aneurysmal Subarachnoid Hemorrhage
5.5.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2021-2033 (USD Million)
5.5.3.3. Others
5.5.3.3.1. Others market, 2021-2033 (USD Million)
5.5.4. Others
5.5.4.1. Others market, 2021-2033 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By End Use, 2021-2033 (USD Million)

6.1. Definition and Scope
6.2. Segment Dashboard
6.3. End Use Market Share Analysis, 2025 & 2033
6.4. Global Neurovascular Devices Market, by End Use, 2021 to 2033
6.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033
6.5.1. Hospital
6.5.1.1. Hospital market, 2021-2033 (USD Million)
6.5.2. Specialty clinics
6.5.2.1. Specialty clinics market, 2021-2033 (USD Million)
6.5.3. Others
6.5.3.1. Others market, 2021-2033 (USD Million)

Chapter 7. Neurovascular Devices Market: Regional Estimates & Trend Analysis

7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts, 2021-2033 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts, 2021-2033 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts, 2021-2033 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts, 2021-2033 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts, 2021-2033 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts, 2021-2033 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts, 2021-2033 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts, 2021-2033 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts, 2021-2033 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts, 2021-2033 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts, 2021-2033 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts, 2021-2033 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts, 2021-2033 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts, 2021-2033 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts, 2021-2033 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts, 2021-2033 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts, 2021-2033 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts, 2021-2033 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts, 2021-2033 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts, 2021-2033 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts, 2021-2033 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts, 2021-2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Global Key company market share analysis, 2025
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Stryker
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Terumo Corporation
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Penumbra, Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Johnson & Johnson and its affiliates
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. MicroPort Scientific Corporation
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Acandis GmbH
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. NeuroSafe Medical Co., Ltd.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Rapid Medical
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Evasc Neurovascular Enterprises
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Lepu Medical Technology(Beijing) Co., Ltd.
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives
8.3.16. phenox GmbH (Wallaby Medical)
8.3.16.1. Company overview
8.3.16.2. Financial performance
8.3.16.3. Product benchmarking
8.3.16.4. Strategic initiatives
8.4. Heat Map Analysis/ Company Market Position Analysis
8.5. Estimated Company Market Share Analysis, 2025
8.6. List of Other Key Market Players-

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America neurovascular devices market, by country, 2021-2033 (USD Million)
Table 4. North America neurovascular devices market, by device, 2021-2033 (USD Million)
Table 5. North America neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 6. North America neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 7. U.S. neurovascular devices market, by device, 2021-2033 (USD Million)
Table 8. U.S. neurovascular devices, by therapeutic application, 2021-2033 (USD Million)
Table 9. U.S. neurovascular devices, by end use, 2021-2033 (USD Million)
Table 10. Canada neurovascular devices market, by device, 2021-2033 (USD Million)
Table 11. Canada neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 12. Canada neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 13. Mexico neurovascular devices market, by device, 2021-2033 (USD Million)
Table 14. Mexico neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 15. Mexico neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 16. Europe neurovascular devices market, by country, 2021-2033 (USD Million)
Table 17. Europe neurovascular devices market, by device, 2021-2033 (USD Million)
Table 18. Europe neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 19. Europe neurovascular devices market, by size, 2021-2033 (USD Million)
Table 20. Europe neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 21. UK neurovascular devices market, by device, 2021-2033 (USD Million)
Table 22. UK neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 23. UK neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 24. Germany neurovascular devices market, by device, 2021-2033 (USD Million)
Table 25. Germany neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 26. Germany neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 27. France neurovascular devices market, by device, 2021-2033 (USD Million)
Table 28. France neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 29. France neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 30. Italy neurovascular devices market, by device, 2021-2033 (USD Million)
Table 31. Italy neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 32. Italy neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 33. Spain neurovascular devices market, by device, 2021-2033 (USD Million)
Table 34. Spain neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 35. Spain neurovascular devices market, by size, 2021-2033 (USD Million)
Table 36. Spain neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 37. Norway neurovascular devices market, by device, 2021-2033 (USD Million)
Table 38. Norway neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 39. Norway neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 40. Sweden neurovascular devices market, by device, 2021-2033 (USD Million)
Table 41. Sweden neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 42. Sweden neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 43. Denmark neurovascular devices market, by device, 2021-2033 (USD Million)
Table 44. Denmark neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 45. Denmark neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 46. Asia Pacific neurovascular devices market, by country, 2021-2033 (USD Million)
Table 47. Asia Pacific neurovascular devices market, by device, 2021-2033 (USD Million)
Table 48. Asia Pacific neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 49. Asia Pacific neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 50. China neurovascular devices market, by device, 2021-2033 (USD Million)
Table 51. China neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 52. China neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 53. Japan neurovascular devices market, by device, 2021-2033 (USD Million)
Table 54. Japan neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 55. Japan neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 56. India neurovascular devices market, by device, 2021-2033 (USD Million)
Table 57. India neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 58. India neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 59. Australia neurovascular devices market, by device, 2021-2033 (USD Million)
Table 60. Australia neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 61. Australia neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 62. South Korea neurovascular devices market, by device, 2021-2033 (USD Million)
Table 63. South Korea neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 64. Thailand neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 65. Thailand neurovascular devices market, by device, 2021-2033 (USD Million)
Table 66. Thailand neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 67. Thailand neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 68. Latin America neurovascular devices market, by country, 2021-2033 (USD Million)
Table 69. Latin America neurovascular devices market, by device, 2021-2033 (USD Million)
Table 70. Latin America neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 71. Latin America neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 72. Brazil neurovascular devices market, by device, 2021-2033 (USD Million)
Table 73. Brazil neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 74. Brazil neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 75. Argentina neurovascular devices market, by device, 2021-2033 (USD Million)
Table 76. Argentina neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 77. Argentina neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 78. Middle East & Africa neurovascular devices market, by country, 2021-2033 (USD Million)
Table 79. Middle East & Africa neurovascular devices market, by device, 2021-2033 (USD Million)
Table 80. Middle East & Africa neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 81. Middle East & Africa neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 82. South Africa neurovascular devices market, by device, 2021-2033 (USD Million)
Table 83. South Africa neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 84. South Africa neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 85. Saudi Arabia neurovascular devices market, by device, 2021-2033 (USD Million)
Table 86. Saudi Arabia neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 87. Saudi Arabia neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 88. UAE neurovascular devices market, by device, 2021-2033 (USD Million)
Table 89. UAE neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 90. UAE neurovascular devices market, by end use, 2021-2033 (USD Million)
Table 91. Kuwait neurovascular devices market, by device, 2021-2033 (USD Million)
Table 92. Kuwait neurovascular devices market, by therapeutic application, 2021-2033 (USD Million)
Table 93. Kuwait neurovascular devices market, by end use, 2021-2033 (USD Million)

List of Figures

Figure 1 Neurovascular devices market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market outlook (2025)
Figure 10 Segment Outlook
Figure 11 Strategy framework
Figure 12 Penetration & growth prospect mapping
Figure 13 Market driver relevance analysis (Current & future impact)
Figure 14 Market restraint relevance analysis (Current & future impact)
Figure 15 Porter’s five forces analysis
Figure 16 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 17 Neurovascular devices market: Device movement analysis
Figure 18 Neurovascular devices market device outlook: Key takeaways
Figure 19 Cerebral embolization and aneurysm coiling devices market, 2021-2033 (USD Million)
Figure 20 Embolic coils market, 2021-2033 (USD Million)
Figure 21 Flow diverters market, 2021-2033 (USD Million)
Figure 22 Liquid embolic agents market, 2021-2033 (USD Million)
Figure 23 Cerebral angioplasty and stenting systems market, 2021-2033 (USD Million)
Figure 24 Carotid artery stents market, 2021-2033 (USD Million)
Figure 25 Embolic protection systems devices market, 2021-2033 (USD Million)
Figure 26 Neurothrombectomy devices market, 2021-2033 (USD Million)
Figure 27 Clot retrieval devices market, 2021-2033 (USD Million)
Figure 28 Suction devices market, 2021-2033 (USD Million)
Figure 29 Vascular snares market, 2021-2033 (USD Million)
Figure 30 Support devices market, 2021-2033 (USD Million)
Figure 31 Micro catheters market, 2021-2033 (USD Million)
Figure 32 Guidewires market, 2021-2033 (USD Million)
Figure 33 Size market, 2021-2033 (USD Million)
Figure 34 0.027"market, 2021-2033 (USD Million)
Figure 35 0.021" market, 2021-2033 (USD Million)
Figure 36 0.021" market, 2021-2033 (USD Million)
Figure 37 0.071" market, 2021-2033 (USD Million)
Figure 38 0.046" market, 2021-2033 (USD Million)
Figure 39 0.019" market, 2021-2033 (USD Million)
Figure 40 0.013" market, 2021-2033 (USD Million)
Figure 41 0.058" market, 2021-2033 (USD Million)
Figure 42 0.068" market, 2021-2033 (USD Million)
Figure 43 Others market, 2021-2033 (USD Million)
Figure 44 Trans radial access devices market, 2021-2033 (USD Million)
Figure 45 Neurovascular devices market: Therapeutic application movement analysis
Figure 46 Neurovascular devices market therapeutic applications outlook: Key takeaways
Figure 47 Stroke market, 2021-2033 (USD Million)
Figure 48 Cerebral artery stenosis market, 2021-2033 (USD Million)
Figure 49 Cerebral aneurysm market, 2021-2033 (USD Million)
Figure 50 Aneurysmal subarachnoid hemorrhage market, 2021-2033 (USD Million)
Figure 51 Others market, 2021-2033 (USD Million)
Figure 52 Others market, 2021-2033 (USD Million)
Figure 53 Neurovascular devices market: End use movement analysis
Figure 54 Neurovascular devices market end use outlook: Key takeaways
Figure 55 Hospital market, 2021-2033 (USD Million)
Figure 56 Specialty clinics market, 2021-2033 (USD Million)
Figure 57 Others market, 2021-2033 (USD Million)
Figure 58 Regional outlook, 2025 & 2033
Figure 59 North America neurovascular devices market, 2021-2033 (USD Million)
Figure 60 U.S. neurovascular devices market, 2021-2033 (USD Million)
Figure 61 Canada neurovascular devices market, 2021-2033 (USD Million)
Figure 62 Mexico neurovascular devices market, 2021-2033 (USD Million)
Figure 63 Europe neurovascular devices market, 2021-2033 (USD Million)
Figure 64 UK neurovascular devices market, 2021-2033 (USD Million)
Figure 65 Germany neurovascular devices market, 2021-2033 (USD Million)
Figure 66 France neurovascular devices market, 2021-2033 (USD Million)
Figure 67 Italy neurovascular devices market, 2021-2033 (USD Million)
Figure 68 Spain neurovascular devices market, 2021-2033 (USD Million)
Figure 69 Norway neurovascular devices market, 2021-2033 (USD Million)
Figure 70 Denmark neurovascular devices market, 2021-2033 (USD Million)
Figure 71 Sweden neurovascular devices market, 2021-2033 (USD Million)
Figure 72 Asia Pacific neurovascular devices market, 2021-2033 (USD Million)
Figure 73 Japan neurovascular devices market, 2021-2033 (USD Million)
Figure 74 China neurovascular devices market, 2021-2033 (USD Million)
Figure 75 India neurovascular devices market, 2021-2033 (USD Million)
Figure 76 Australia neurovascular devices market, 2021-2033 (USD Million)
Figure 77 South Korea neurovascular devices market, 2021-2033 (USD Million)
Figure 78 Thailand neurovascular devices market, 2021-2033 (USD Million)
Figure 79 Latin America neurovascular devices market, 2021-2033 (USD Million)
Figure 80 Brazil neurovascular devices market, 2021-2033 (USD Million)
Figure 81 Argentina neurovascular devices market, 2021-2033 (USD Million)
Figure 82 MEA neurovascular devices market, 2021-2033 (USD Million)
Figure 83 South Africa neurovascular devices market, 2021-2033 (USD Million)
Figure 84 Saudi Arabia neurovascular devices market, 2021-2033 (USD Million)
Figure 85 UAE neurovascular devices market, 2021-2033 (USD Million)
Figure 86 Kuwait neurovascular devices market, 2021-2033 (USD Million)

Companies Mentioned

The leading players profiled in this Neurovascular Devices market report include:

Medtronic
Stryker
Johnson & Johnson and its affiliates
Penumbra, Inc.
MicroPort Scientific Corporation
Terumo Corporation
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
NeuroSafe Medical Co., Ltd.
Rapid Medical
Evasc Neurovascular Enterprises
Lepu Medical Technology(Beijing) Co., Ltd.
Acandis GmbH
phenox GmbH (Wallaby Medical)

Table Information

Report Attribute	Details
No. of Pages	110
Published	February 2026
Forecast Period	2025 - 2033
Estimated Market Value ( USD ) in 2025	$ 7.78 Billion
Forecasted Market Value ( USD ) by 2033	$ 11.91 Billion
Compound Annual Growth Rate	5.4%
Regions Covered	Global
No. of Companies Mentioned	14

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5360EUR$5,950USD£4,630GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6260EUR$6,950USD£5,408GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8062EUR$8,950USD£6,965GBP

Global Neurovascular Devices Market Report Segmentation

Why You Should Buy This Report

This report addresses:

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033

Neurovascular Devices/Interventional Neurology - Market Insights, Competitive Landscape, and Market Forecast - 2032

Neurovascular Devices Market - Global Forecast 2026-2032

Neurovascular Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Neurovascular Devices / Interventional Neurology - Global Strategic Business Report